EUVIMEDEUVIMED entdecken
Video/AudioValidierungsstudie

Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma

Shuiling Xie, Changfeng Liao, Liuyan Xin, Chuanming Lin

Journal of Visualized Experiments · 2026

DOI: 10.3791/69890 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Shuiling Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Gannan Medical University. Hauptthemen laut MEDLINE: Multiple Myeloma, High-Throughput Nucleotide Sequencing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHigh-Throughput Nucleotide SequencingHumansNeoplasm, ResidualReceptors, Antigen, B-CellReceptors, Antigen, T-CellFlow CytometryCell Line, Tumor

Substanzen

Receptors, Antigen, B-CellReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • The First Affiliated Hospital of Gannan Medical University.
  • The First Affiliated Hospital of Gannan Medical University; lcm1430@163.com.

Zitieren

APA

Xie, S., Liao, C., Xin, L., & Lin, C. (2026). Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma. Journal of Visualized Experiments. https://doi.org/10.3791/69890

Vancouver

Xie S, Liao C, Xin L, Lin C. Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma. Journal of Visualized Experiments. 2026. doi:10.3791/69890

BibTeX
@article{Xie2026,
  author = {Xie, Shuiling and Liao, Changfeng and Xin, Liuyan and Lin, Chuanming},
  title = {Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/69890}
}
Kostenlos starten →